https://www.thebody.com/article/cabenuva-first-long-acting-injectable-hiv-regimen
Approved HIV MedicationsNews Analysis

Cabenuva, the First Long-Acting Injectable HIV Regimen, Is Here; Now, Who Will Take It?

flaming pills
wwing via iStock

    FLAIR study results: CROI 2019. (2019). "Long-Acting Cabotegravir + Rilpivirine for HIV Maintenance: FLAIR Week 48 Results." croiconference.org/sessions/long-acting-cabotegravir-rilpivirine-hiv-maintenance-flair-week-48-results

    ATLAS study results: CROI 2019. (2019). "Long-Acting Cabotegravir + Rilpivirine as Maintenance Therapy: ATLAS Week 48 Results." croiconference.org/sessions/long-acting-cabotegravir-rilpivirine-maintenance-therapy-atlas-week-48-results

    Tim Murphy

    Tim Murphy

    @TimMurphyNYC

    Tim Murphy, based in Brooklyn, has been writing about HIV/AIDS for 25 years, for publications and organizations including TheBody, TheBodyPro, POZ, New York Magazine, The Nation, Housing Works, and Lambda Legal.